Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione

Neuroscience

Volumn 84, Issue 1, 1998, Pages 7-10

  Green, P S ^a   Gridley, K E ^a   Simpkins, J W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ESTRADIOL; ESTROGEN RECEPTOR; GLUTATHIONE;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL NUCLEUS; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANIMALS; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ESTRENES; GLUTATHIONE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, ESTROGEN;

EID: 0031940591     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00595-2     Document Type: Article

References (29)

1. Baronti F., Davis T. L., Boldry R. C., Moiuradian M. M., Chase T. N. Deprenyl effects on levodopa pharmacodynamics, mood, and free radical scavenging. Neurology. 42:1992;541-544.
2. Behl C., Widmann M., Trapp T., Holspoer F. 17β-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. biophys. Res. Commun. 216:1995;473-482.
3. Behl C., Skutella T., Lezoualch F., Post A., Widmann M., Newton C. J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molec. Pharmac. 51:1997;535-541.
4. Benzi G., Moretti A. Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system. Free Rad. Biol. Med. 19:1995;77-101.
5. Bishop J., Simpkins J. W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Molec. cell. Neurosci. 5:1994;303-308.
6. Goodman Y., Bruce A. J., Cheng B., Mattson M. P. Estrogen attenuates and corticosterone exacerbates excitoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
7. Green P. S., Gridley K. E., Simpkins J. W. Estradiol protects against β-amyloid (25-35)-induced toxicity in SK-N-SH cells. Neurosci. Lett. 218:1996;165-168.
8. Green P. S., Bishop J., Simpkins J. W. 17α-estradiol exerts neuroprotective effects in SK-N-SH cells. J. Neurosci. 17:1997;511-515.
9. Green P. S., Gordon K. and Simpkins J. W. (1997) Phenolic A ring requirement for the neuroprotective effects of steroids. J. Ster. Biochem. molec. Biol. (in press).
10. Kruman I., Bruce-Keller A. J., Bredesen D., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
11. Kuiper G. J., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
12. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., Mattson M. P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
13. Morley P., Whitfield J. F., Vanderhyden B. C., Tsang B. J., Schwartz J. L. A new, non-genomic estrogen action: the rapid release of intracellular calcium. Endocrinology. 131:1992;1305-1312.
14. Miranda R., Sohrabji F., Singh M., Toran-Allerand D. Nerve growth factor (NGF) regulation of estrogen receptors in explant cultures of the developing forebrain. J. Neurobiol. 31:1996;77-87.
15. Nakao J., Chang W., Murota S., Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Atherosclerosis. 38:1981;75-80.
16. Nemere I., Norman A. W. Steroid hormone actions at the plasma membrane: inducted calcium uptake and exocytotic events. Molec. cell. Endocrinol. 80:1992;c165-c169.
17. Paganini-Hill A., Henderson V. W. Estrogen deficiency and risk of Alzheimer's disease. Am. J. Epidemiol. 140:1994;251-256.
18. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
19. Rabbani O., Panikar K., Rajakumar G., King M., Bodor N., Meyer E. M., Simpkins J. W. 17β-estradiol attenuates fimbra lesion-induced decline of ChAT-immunoreactive neurons in the rat medial septum. Expl Neurol. 146:1997;179-186.
20. Sato K., Saito H., Katsuki H. Synergism of tocopherol and ascorbate on the survival of cultured brain neurones. NeuroReport. 4:1993;1179-1182.
21. Shi J., Zhang Y.Q. and Simpkins J. W. (1997) Effects of 17β-estradiol on glucose transporter 1 expression and endothelial cell survival following focal ischemia in the rat. Expl Brain Res. (in press).
22. Simpkins J. W., Green P. S., Gordon K., Tumar N. Phenolic A-ring requirement for the neuroprotective effects of steroids. Soc. Neurosci. Abstr. 22:1995;2122.
23. Singer C. A., Rogers K. L., Strickland T. M., Dorsa D. M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci. Lett. 212:1996;13-16.
24. Sugioka K., Shimosegawa Y., Nakano M. Estrogens as natural antioxidants of membrane phospholipid peroxidation. Fedn Eur. biochem. Socs Lett. 210:1987;37-39.
25. Tang M. X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk an age of onset of Alzheimer's disease. Lancet. 348:1996;429-432.
26. Tennant J. R. Evaluations of the trypan blue technique for determination of cell viability. Transplantation. 2:1964;685-694.
27. Tyler T. J., Vardaris R. M., Lewis D., Rawitch A. B. Gonadal steroids: effects on the excitability of hippocampal pyramidal cells. Science. 209:1980;1017-1019.
28. Winkler B. S., Orselli S. M., Rex T. S. The redox couple between glutathione and ascorbic acid: a chemical and physiological perspective. Free Rad. Biol. Med. 17:1994;333-349.
29. Wong M., Moss R. L. Electrophysiological evidence for a rapid membrane action of gonadal steroids, 17β-estradiol, on CA1 pyramidal neurons of the rat hippocampus. Brain Res. 543:1991;148-152.